A study carried out by Fumagalli et al. [58] analyzed the genetic profiles of patients and looked at the impacts on metabolism. They especially looked at human CHC22 clathrin, which performs a central part in intracellular website traffic of insulin-responsive glucose transporter four (GLUT4). The GLUT4 pathway would be the dominant system utilized